$15.95
-0.03-0.19%
Last update: 4:53 PM
15 minutes delayed
Comments
Loading...
Tourmaline Bio
TRMLNASDAQ
Tourmaline Bio (TRML) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTourmaline Bio (NASDAQ:TRML) Stock Quotes, Forecast and News Summary
Tourmaline Bio Stock (NASDAQ: TRML) stock price, news, charts, stock research, profile.
| Open | $15.62 |
| Close | - |
| Volume / Avg. | 22.76K / 388.07K |
| Day Range | 15.25 - 15.97 |
| 52 Wk Range | 9.18 - 48.31 |
| Market Cap | $409.06M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 55 |
| Short Interest | 6.7% |
| Days to Cover | 2.09 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Tourmaline Bio Inc
Sector
Health Care
Industry
Biotechnology
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop t...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tourmaline Bio (TRML) stock?
You can purchase shares of Tourmaline Bio (NASDAQ:TRML) through any online brokerage.
Who are Tourmaline Bio (TRML) competitors?
Other companies in Tourmaline Bio’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Korro Bio (NASDAQ:KRRO).
What is the target price for Tourmaline Bio (TRML) stock?
There is no analysis for Tourmaline Bio.
What is the forecast for Tourmaline Bio (TRML) stock?
Tourmaline Bio has a consensus price target of $61.80.
Current stock price for Tourmaline Bio (TRML)?
The stock price for Tourmaline Bio (NASDAQ: TRML) is $15.95 last updated July 16, 2024 at 4:53 PM EDT.
Does Tourmaline Bio (TRML) pay a dividend?
There are no upcoming dividends for Tourmaline Bio.
When is Tourmaline Bio (NASDAQ:TRML) reporting earnings?
Tourmaline Bio’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Tourmaline Bio (TRML) going to split?
There is no upcoming split for Tourmaline Bio.
What sector and industry does Tourmaline Bio (TRML) operate in?
Tourmaline Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.